# Detection of Cerebral Proteinopathy in Alzheimer's Disease Through Magnetic Resonance Imaging

> **NCT03846232** · — · COMPLETED · sponsor: **Barcelonabeta Brain Research Center, Pasqual Maragall Foundation** · enrollment: 60 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT03846232
- **Lead sponsor:** Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-12
- **Primary completion:** 2020-11-30
- **Final completion:** 2022-12-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03846232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03846232, "Detection of Cerebral Proteinopathy in Alzheimer's Disease Through Magnetic Resonance Imaging". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03846232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*